Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    An example of the visual output provided by the new QuanSA PyMOL plugin. m32 is approximately 50 times more potent than the structurally similar m01, despite having near identical patterns of hydrogen bonding (red and blue cones). The difference is explained by additional steric contributions indicated by the surface patches highlighted by the black arrows.
    24 March 2026

    Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions

    New user interface provides visual insights to guide compound optimisation

    SLAS - Society for Laboratory Automation and Screening
    23 March 2026

    SLAS announces the cohort for Innovation AveNEW at SLAS Europe 2026

    Vienna, Austria, 23 March 2026: SLAS, the Society of Laboratory Automation and Screening, has introduced the 12 companies selected for the Innovation AveNEW program at SLAS Europe 2026 Conference and Exhibition, taking place 19-21 May in Vienna, Austria. Innovation AveNEW is the Society...

    Abselion Logo
    23 March 2026

    Abselion appoints Dale Gordon as Chair

    Bioprocessing leader to drive continued commercial development and international expansion ...

    ictured inside the perfusion suite are (left to right) Prof Mike Nicholson, Prof Sarah Hosgood, Mr Neil Russell, Prof Chris Watson, Mr Rohit Gaurav and Mr Andrew Butler, with the kidney perfusion machine on the left and liver perfusion machine on the right
    20 March 2026

    Trust chosen to be specialist organ perfusion centre

    Addenbrooke’s has welcomed an announcement it is to become one of the first pilot assessment and recovery centres (ARC) in a bid to boost the number of life-saving organ transplants. ...

    Annoying Teams habit fixed
    19 March 2026

    Microsoft finally fixes these Teams issues

    If there’s one thing guaranteed to test your patience during a busy workday, it’s a messaging app that doesn’t behave the way you expect it to.For a tool that millions of us rely on every day, Microsoft Teams does an impressive job of keeping organisations connected and conversatio...

    logo
    18 March 2026

    ProImmune and the Roslin Institute collaborate to advance animal health science

    Partnership will validate high quality, species specific Ankyron binders for key animal health science applications, including prevention and monitoring of zoonotic diseases ...

    DNA Script’s SYNTAX® platform
    18 March 2026

    DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia

    Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hoursEstablishes direct distribution networks across Latin America, Japan and South KoreaParis, France, 17 March 2026: DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand acc...

    Illustration of the convergence between electricity grid capacity, AI compute infrastructure and life sciences research systems.
    17 March 2026

    AI infrastructure and grid reform: what it could mean for life sciences ecosystems

    Recent discussions about reforming the UK’s electricity grid connection process have drawn attention to rapidly expanding demand for AI data centres. Government proposals to prioritise strategically important projects — including new AI infrastructure and designated AI Growth Zones — re...

    Why Terminology Matters in Clinical Trial Device Development
    16 March 2026

    Clear terminology, faster clinical device development

    In this article, we explore what ‘clinical trial device’ really means, why consistent terminology is crucial to a shared understanding of the stage of development, and how this links to what regulators expect before approving a clinical investigation. ...

    Using off-the-shelf components in product development
    16 March 2026

    De-risking development with off-the-shelf modules

    Off‑the‑shelf electronics modules are often more expensive and are sometimes assumed to be complex or not an exact fit for specific requirements, yet these perceptions often overlook the real advantages they bring.Many of these modules have been refined through multiple development cycl...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 25
    • Page 26
    • Current page 27
    • Page 28
    • Page 29
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS